Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Otto

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Virulence|December 24, 2010
Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance elementMichael Otto
Expert Review of Anti-Infective Therapy|April 21, 2011
Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections?Michael Otto
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 25, 2008
Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodiesMichael Otto
Microbiology Spectrum|August 18, 2018
Staphylococcal BiofilmsMichael Otto
Cellular Microbiology|July 4, 2012
MRSA virulence and spreadMichael Otto
Biomolecular Concepts|December 2, 2014
How colonization factors are linked to outbreaks of methicillin-resistant Staphylococcus aureus: the roles of SasX and ACMEMichael Otto
International Journal of Medical Microbiology : IJMM|March 23, 2013
Community-associated MRSA: what makes them special?Michael Otto
The Journal of Infectious Diseases|March 30, 2012
How Staphylococcus aureus breaches our skin to cause infectionMichael Otto
FEMS Microbiology Letters|December 16, 2004
Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?Michael Otto
Genome Medicine|July 26, 2017
Next-generation sequencing to monitor the spread of antimicrobial resistanceMichael Otto
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Virulence|December 24, 2010
Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance elementMichael Otto
Expert Review of Anti-Infective Therapy|April 21, 2011
Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections?Michael Otto
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 25, 2008
Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodiesMichael Otto
Microbiology Spectrum|August 18, 2018
Staphylococcal BiofilmsMichael Otto
Cellular Microbiology|July 4, 2012
MRSA virulence and spreadMichael Otto
Biomolecular Concepts|December 2, 2014
How colonization factors are linked to outbreaks of methicillin-resistant Staphylococcus aureus: the roles of SasX and ACMEMichael Otto
International Journal of Medical Microbiology : IJMM|March 23, 2013
Community-associated MRSA: what makes them special?Michael Otto
The Journal of Infectious Diseases|March 30, 2012
How Staphylococcus aureus breaches our skin to cause infectionMichael Otto
FEMS Microbiology Letters|December 16, 2004
Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?Michael Otto
Genome Medicine|July 26, 2017
Next-generation sequencing to monitor the spread of antimicrobial resistanceMichael Otto
Pageof 30